|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-7-9
|
|
pubmed:abstractText |
There is currently no optimal second-line treatment after failure of Helicobacter pylori triple therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
pubmed-author:EnjojiAA,
pubmed-author:FujimotoCC,
pubmed-author:FurusuHH,
pubmed-author:HirakataYY,
pubmed-author:InoueKK,
pubmed-author:IsomotoHH,
pubmed-author:KohnoSS,
pubmed-author:MizutaYY,
pubmed-author:MuraseKK,
pubmed-author:MurataII,
pubmed-author:OmagariKK,
pubmed-author:ShimadaSS,
pubmed-author:YamakawaMM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
101-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12848631-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:12848631-Adult,
pubmed-meshheading:12848631-Aged,
pubmed-meshheading:12848631-Amoxicillin,
pubmed-meshheading:12848631-Anti-Bacterial Agents,
pubmed-meshheading:12848631-Anti-Ulcer Agents,
pubmed-meshheading:12848631-Benzimidazoles,
pubmed-meshheading:12848631-Drug Resistance, Bacterial,
pubmed-meshheading:12848631-Drug Therapy, Combination,
pubmed-meshheading:12848631-Female,
pubmed-meshheading:12848631-Helicobacter Infections,
pubmed-meshheading:12848631-Helicobacter pylori,
pubmed-meshheading:12848631-Humans,
pubmed-meshheading:12848631-Male,
pubmed-meshheading:12848631-Metronidazole,
pubmed-meshheading:12848631-Middle Aged,
pubmed-meshheading:12848631-Omeprazole,
pubmed-meshheading:12848631-Penicillins,
pubmed-meshheading:12848631-Prospective Studies,
pubmed-meshheading:12848631-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.
|
|
pubmed:affiliation |
Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan. hhisomot@net.nagasaki-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
